Biliary excretion of radiochromium.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to L Tetreault.
Explore the source record for details and available documents.
In order to test the sensitivity of different techniques in the diagnosis of sacroiliitis, we have made a prospective and non-controlled study of 22 patients using standard radiography of the sacroiliac joint; conventional tomography and axial scintigraphy (calculation of an ISI sacroiliac index). The normal upper limit of the sacroiliac index (1.42) was studied in parallel, using a group of 63 control subjects. Correlation between the radiological examinations was average, but was very poor between radiology and scintigraphy. Conventional tomography and calculation of the sacroiliac index were of equal value diagnostically. Clear images of juxta-articular geodes were seen during scanning, but were not taken into account in the diagnosis. They may represent the onset of larger erosions and need to be verified.
Bioavailability of an oral preparation of the antineoplastic drug etoposide (VP-16) was studied in 13 patients with advanced malignancies. An initial pilot study involving three patients suggested that approximately 50% of an orally administered dose was absorbed. Ten additional patients were randomized to receive either 100 mg/m2/day iv or 200 mg/m2/day orally. Three weeks later, the alternate dose schedule was administered. Plasma samples were assayed for VP-16 using a high-pressure liquid chromatography technique. Comparison of the area under concentration-time curves (C X t) revealed that 17%-72% (mean, 52%) of an orally administered dose was absorbed. Absorption was less than 40% for only one patient. For oral and iv preparations, mean peak plasma VP-16 concentrations were 9.6 and 13.0 micrograms/ml, mean alpha-half-lives were 0.96 and 0.82 hour, mean beta-half-lives were 7.2 and 6.8 hours, mean C X t values were 75.9 and 75.3 mg/L/hour, mean plasma clearances were 1.44 and 1.45 L/hour/m2, and mean extrapolated volumes of distribution were 15.2 and 16.9 L/m2, respectively. The half-life for oral absorption was 0.44 hour and peak plasma concentrations were noted 0.5-3 hours after oral drug administration. Granulocyte count nadirs tended to be lower in patients with high C X t values and low plasma clearance values. Granulocytopenia was dose-limiting. Gastrointestinal toxicity was extremely mild. We recommend doses of oral VP-16 of 800 mg/m2/course over 3-5 days for patients with a moderate amount of prior treatment. It is probable that previously untreated patients will tolerate a higher dose and that heavily pretreated patients will require a lower dose.
Explore the source record for details and available documents.
A prospective, randomized double-blind study with crossover using bromocriptine and placebo was performed on a group of 17 infertile males with idiopathic oligozoospermia. Twelve patients completed the duration of this study of eight months by receiving 5 mg of bromocriptine per day for four months followed by four months of placebo or vice versa. Prior to treatment, the sperm count was 8.76 +/- 1.32 (10(6)/ml). The hormonal profile was performed prior to treatment and included estimation of prolactin, T3, T4, thyroid stimulating hormone (TSH), testosterone, follicle stimulating hormone (FSH), and plasma LH. Stimulation studies using LHRH and TRH were also performed. All hormonal estimations were within normal limits. Compared to placebo, bromocriptine had no significant effect on sperm analysis, or basic hormonal profile. The stimulation test with luteinizing hormone releasing hormone (LHRH) was unchanged except for the basic plasma testosterone, which increased. The prolactin decreased following the thyrotropin releasing hormone (TRH) stimulation. Two pregnancies were noted four to six weeks following the end of treatment. Bromocriptine did not seem to be more effective than placebo in the treatment of idiopathic oligozoospermia.
The orbicularis oculi branch of the facial nerve was transected in two groups of 15 cats. Following section of the nerve, a specimen was removed for histological studies; then, using microscopic techniques the epineurium was sutured (nylon 10:0) in the first group, and the perineurium in the second. They were then followed for 100 days. Results rely on clinical (complete closure of the eye), electrophysiological (summation potentials), and histological (fiber count) evaluations. Judging from the relative density and diameters of the fibers, epineural sutures result in better regeneration than perineural sutures. With the tremendous importance of the absence of tension on the suture line in mind, it seems that the technique of choice for monofascicular nerves, as in the pyramidal and tympanic segments of the facial nerve, is epineural suture. Despite the slight advantage of epineural suture over perineural suture as evidenced by histological evaluation, there was no clinical difference. The distal fascicular distribution of facial nerve fibers and their spatial distribution make perineural (fascicular) sutures the method of choice when anastomosis becomes necessary in the vertical portion and in the portion distal to the stylomastoid foramen.
The purpose of this project was to attempt to outline the natural history of serous otitis media. Sixty-eight children with uni or bilateral serous otitis media were placed under observation for a six week period. They were all left untreated. Otoscopy, impedance, and audiogram measurements were used to monitor the evolution of the disease. Results showed that spontaneous resolution occurred in 35 per cent of cases. Girls were cured more frequently than boys. Furthermore, the disease receded more satisfactorily in the right than in the left ear. Within our group of patients, age was not a factor in the evolution of the otitis. Finally, the impedancometry and audiometry were not useful in assessing the probable evolution of this disease.
The difference between gout and rheumatoid arthritis was reproduced experimentally in the rat by combining adjuvant arthritis with an oxonate uric acid raising diet and injections of crystals of sodium urate. The factorial experiment using 3 factors confirms the inhibition or arthritis by a uric acid raising diet and shows that the injections of crystals, which preceed the injection of Freund's adjuvant, increase the arthritic lesions in normo-uricemic rats and reduces them slightly in hyperuricemic rats. This effect of the injection of crystals increases gradually with time.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.